UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
RESEARCH & DEVELOPMENT

ADMA Biologics

Groundbreaking Immunotechnology, One Connection at a Time

ADMA Biologics logo

ADMA Biologics

Groundbreaking Immunotechnology, One Connection at a Time

Visit WebsiteContact Company

About ADMA Biologics

Three FDA-licensed and authorised drugs made by ADMA Biologics, an end-to-end biopharmaceutical firm, include ASCENIVTM (Immune Globulin Intravenous - slra, Human), BIVIGAM® (Immune Globulin Intravenous, Human), and NABI-HB® (hepatitis B immune globulin, human).

Similar Companies

More in Research & Development

A

AdoRx Therapeutics

The UK-based drug development startup AdoRx Therapeutics is funded by Epidarex Capital and Sixth Element Capital. AdoRx Therapeutics is working to develop novel cancer treatments that target the adenosine pathway. Adenosine is a key component of the tumour microenvironment that helps cancer avoid the immune system.

View profile
A

Adcentrx Therapeutics

A biotechnology business called Adcentrx Therapeutics is dedicated to quickening the development of novel protein conjugate therapeutics for cancer and other serious illnesses. Adcentrx aims to create the next generation of tailored medicines by fusing the disease-fighting potency of small molecule payloads with the precise targeting of biologics.

View profile
I

International Biopharmaceutical Industry

International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally. Providing a proven supportive means of communication to the pharmaceutical, biopharmaceutical, nutraceutical, and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing, and communication strategies.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy